ORBIMED ADVISORS LLC Insider Trading for November 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of ORBIMED ADVISORS LLC for November 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 29 2019 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 72.13 | 2,306 | 166,332 | 1,348,326 | 1.4 M to 1.3 M (-0.17 %) |
Nov 29 2019 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 71.67 | 47,981 | 3,438,798 | 1,350,632 | 1.4 M to 1.4 M (-3.43 %) |
Nov 29 2019 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 70.60 | 3,100 | 218,860 | 1,398,613 | 1.4 M to 1.4 M (-0.22 %) |
Nov 29 2019 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 70.16 | 50,478 | 3,541,536 | 1,401,713 | 1.5 M to 1.4 M (-3.48 %) |
Nov 29 2019 | INSP | Inspire Medical Sy ... | ORBIMED ADVISORS LLC | Director | Sell | S | 69.55 | 20,135 | 1,400,389 | 1,452,191 | 1.5 M to 1.5 M (-1.37 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 28.65 | 758,623 | 21,734,549 | 758,623 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 28.65 | 758,623 | 21,734,549 | 758,623 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 1.16 | 758,623 | 880,003 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 1.16 | 758,623 | 880,003 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 24,142,419 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 24,142,419 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 11,878,249 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 11,878,249 | 0 | 0 | |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 977,820 | 0 | 3,027,542 | 2 M to 3 M (+47.71 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 977,820 | 0 | 3,027,542 | 2 M to 3 M (+47.71 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 481,095 | 0 | 2,049,722 | 1.6 M to 2 M (+30.67 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 481,095 | 0 | 2,049,722 | 1.6 M to 2 M (+30.67 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 13.00 | 384,615 | 4,999,995 | 1,568,627 | 1.2 M to 1.6 M (+32.48 %) |
Nov 13 2019 | TELA | TELA Bio, Inc. | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 13.00 | 384,615 | 4,999,995 | 1,568,627 | 1.2 M to 1.6 M (+32.48 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 7,944,444 | 0 | 0 | |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,277,858 | 0 | 2,002,221 | 724.4 K to 2 M (+176.41 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | ORBIMED ADVISORS LLC | Director | Buy | P | 16.00 | 418,750 | 6,700,000 | 724,363 | 305.6 K to 724.4 K (+137.02 %) |